{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T17:40:03Z","timestamp":1775842803029,"version":"3.50.1"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"vor","delay-in-days":259,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/j.ctarc.2024.100844","type":"journal-article","created":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T13:31:40Z","timestamp":1726752700000},"page":"100844","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["A review of the efficacy and safety of iodine-125 seed implantation for lung cancer treatment"],"prefix":"10.1016","volume":"41","author":[{"given":"Zhouzhou","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhigang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqi","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyu","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctarc.2024.100844_bib0001","unstructured":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Available from: gco.iarc.fr (accessed May 10, 2023)."},{"issue":"9","key":"10.1016\/j.ctarc.2024.100844_bib0002","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1056\/NEJMra1703413","article-title":"Precision diagnosis and treatment for advanced non-small-cell lung cancer","volume":"377","author":"Reck","year":"2017","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.ctarc.2024.100844_bib0003","doi-asserted-by":"crossref","DOI":"10.3389\/fsurg.2022.1126486","article-title":"Perioperative systemic therapies for non-small-cell lung cancer: Recent advances and future perspectives","volume":"9","author":"Lampridis","year":"2023","journal-title":"Front. Surg."},{"issue":"8","key":"10.1016\/j.ctarc.2024.100844_bib0004","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/S1470-2045(17)30318-2","article-title":"CONVERT Study Team, Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial","volume":"18","author":"Faivre-Finn","year":"2017","journal-title":"Lancet Oncol."},{"issue":"35","key":"10.1016\/j.ctarc.2024.100844_bib0005","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1200\/JCO.2015.62.6812","article-title":"Phase III study of surgery versus definitive concurrent chemoradiotherapy boost in patients with resectable stage IIIa(n2) and selected IIIb non-small-cell lung cancer after induction chemotherapy and concurrent chemoradiotherapy (ESPATUE)","volume":"33","author":"Eberhardt","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ctarc.2024.100844_bib0006","doi-asserted-by":"crossref","unstructured":"J. Conibear J, AstraZeneca UK Limited, Rationale for concurrent chemoradiotherapy for patients with stage III non-small-cell lung cancer. Br. J. Cancer. 123 (Suppl 1) (2020) 10\u201317, doi:10.1038\/s41416-020-01070-6. Dec.","DOI":"10.1038\/s41416-020-01070-6"},{"key":"10.1016\/j.ctarc.2024.100844_bib0007","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13014-015-0349-0","article-title":"Iodine-125 seed brachytherapy for early stage prostate cancer: a single-institution review","volume":"10","author":"Zuber","year":"2015","journal-title":"Radiat. Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2024.100844_bib0008","doi-asserted-by":"crossref","first-page":"49","DOI":"10.5812\/ircmj.4322","article-title":"Long-term results of stereotactic brachytherapy (temporary 125Iodine seeds) for the treatment of low-grade astrocytoma (Grade II)","volume":"15","author":"Shahzadi","year":"2013","journal-title":"Iran Red Crescent Med. J"},{"key":"10.1016\/j.ctarc.2024.100844_bib0009","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1748-717X-7-30","article-title":"Iodine-125 brachytherapy for brain tumours - a review","volume":"7","author":"Schwarz","year":"2012","journal-title":"Radiat. Oncol."},{"issue":"2","key":"10.1016\/j.ctarc.2024.100844_bib0010","first-page":"91","article-title":"Cryosurgery in combination with brachytherapy of iodine-125 seeds for pancreatic cancer","volume":"2","author":"Xu","year":"2013","journal-title":"Gland. Surg."},{"issue":"1","key":"10.1016\/j.ctarc.2024.100844_bib0011","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.brachy.2016.09.002","article-title":"A novel conformal superficial high-dose-rate brachytherapy device for the treatment of nonmelanoma skin cancer and keloids","volume":"16","author":"Ferreira","year":"2017","journal-title":"Brachytherapy.Brachytherapy."},{"issue":"8","key":"10.1016\/j.ctarc.2024.100844_bib0012","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1097\/IGC.0000000000000244","article-title":"Computed tomography-guided 125I seed interstitial implantation in the treatment of recurrent ovarian cancer","volume":"24","author":"Wang","year":"2014","journal-title":"Int. J. Gynecol. Cancer."},{"issue":"Supplement","key":"10.1016\/j.ctarc.2024.100844_bib0013","first-page":"C176","article-title":"Iodine-125 radioactive seed tissue implantation as a remedy treatment for recurrent cervical cancer","volume":"12","author":"Han","year":"2016","journal-title":"J. Cancer Res. Ther."},{"issue":"3","key":"10.1016\/j.ctarc.2024.100844_bib0014","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/hed.24659","article-title":"Postoperative iodine-125 interstitial brachytherapy for the early stages of minor salivary gland carcinomas of the lip and buccal mucosa with positive or close margins","volume":"39","author":"Wu","year":"2017","journal-title":"Head Neck"},{"issue":"4","key":"10.1016\/j.ctarc.2024.100844_bib0015","doi-asserted-by":"crossref","first-page":"403","DOI":"10.5114\/jcb.2022.118117","article-title":"Iodine-125 seeds insertion with trans-arterial chemical infusion for advanced lung cancer: a meta-analysis","volume":"14","author":"Hong","year":"2022","journal-title":"J. Contemp. Brachyther."},{"issue":"1","key":"10.1016\/j.ctarc.2024.100844_bib0016","doi-asserted-by":"crossref","first-page":"81","DOI":"10.5114\/jcb.2023.125582","article-title":"Iodine-125 seed brachytherapy combined with pembrolizumab for advanced non-small-cell lung cancer after failure of first-line chemotherapy: A report of two cases and literature review","volume":"15","author":"Yuan","year":"2023","journal-title":"J Contemp. Brachyther."},{"issue":"2","key":"10.1016\/j.ctarc.2024.100844_bib0017","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/1759-7714.12912","article-title":"2019. Chinese expert consensus workshop report: Guideline for permanent iodine-125 seed implantation of primary and metastatic lung tumors","volume":"10","author":"Zhang","year":"2019","journal-title":"Thorac. Cancer."},{"issue":"1","key":"10.1016\/j.ctarc.2024.100844_bib0018","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.semradonc.2019.08.009","article-title":"Radiobiology: Foundation and new insights in modeling brachytherapy effects","volume":"30","author":"Annede","year":"2020","journal-title":"Semin. Radiat. Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2024.100844_bib0019","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1756-9966-30-35","article-title":"Continuous and low-energy 125I seed irradiation changes DNA methyltransferases expression patterns and inhibits pancreatic cancer tumor growth","volume":"30","author":"Ma","year":"2011","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.ctarc.2024.100844_bib0020","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/s13014-020-01682-5","article-title":"125I seeds irradiation inhibits tumor growth and induces apoptosis by Ki-67, P21, survivin, livin and caspase-9 expression in lung carcinoma xenografts","volume":"15","author":"Jin","year":"2020","journal-title":"Radiat. Oncol."},{"issue":"2","key":"10.1016\/j.ctarc.2024.100844_bib0021","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3892\/or.2014.3255","article-title":"Effect of brachytherapy on NF-\u03baB and VEGF in gastric carcinoma xenografts","volume":"32","author":"Zhang","year":"2014","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ctarc.2024.100844_bib0022","doi-asserted-by":"crossref","first-page":"371","DOI":"10.12659\/MSM.912590","article-title":"Evaluation of iodine-125 interstitial brachytherapy using micro-positron emission tomography\/computed tomography with 18F-fluorodeoxyglucose in hepatocellular carcinoma HepG2 xenografts","volume":"25","author":"Zhu","year":"2019","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.ctarc.2024.100844_bib0023","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/1477-7819-12-222","article-title":"Iodine-125 induces apoptosis via regulating p53, microvessel density, and vascular endothelial growth factor in colorectal cancer","volume":"12","author":"Ma","year":"2014","journal-title":"World J. Surg. Oncol."},{"issue":"5","key":"10.1016\/j.ctarc.2024.100844_bib0024","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.3892\/or.2017.5521","article-title":"125I seed irradiation induces apoptosis and inhibits angiogenesis by decreasing HIF-1\u03b1 and VEGF expression in lung carcinoma xenografts","volume":"37","author":"Xiang","year":"2017","journal-title":"Oncol. Rep."},{"issue":"5","key":"10.1016\/j.ctarc.2024.100844_bib0025","first-page":"2243","article-title":"Inhibition of glioblastoma growth and invasion by 125I brachytherapy in rat glioma model","volume":"9","author":"Chen","year":"2017","journal-title":"Am. J. Transl. Res."},{"issue":"2","key":"10.1016\/j.ctarc.2024.100844_bib0026","first-page":"297","article-title":"Effect of 125I seed implantation on the body's immunity after liver section resection for liver cancer","volume":"30","author":"Xiang","year":"2010","journal-title":"J. South. Med."},{"key":"10.1016\/j.ctarc.2024.100844_bib0027","first-page":"8209","article-title":"Combination of brachytherapy with iodine-125 seeds and systemic chemotherapy versus systemic chemotherapy alone for synchronous extracranial oligometastatic non-small cell lung cancer","volume":"12","author":"Li","year":"2020","journal-title":"Cancer Manag. Res."},{"issue":"6","key":"10.1016\/j.ctarc.2024.100844_bib0028","doi-asserted-by":"crossref","first-page":"527","DOI":"10.5114\/jcb.2017.72605","article-title":"2017. Implantation of computed tomography-guided Iodine-125 seeds in combination with chemotherapy for the treatment of stage III non-small cell lung cancer","volume":"9","author":"Huo","year":"2017","journal-title":"J. Contemp. Brachyther."},{"key":"10.1016\/j.ctarc.2024.100844_bib0029","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1186\/s12885-015-1657-3","article-title":"Combination of Iodine-125 brachytherapy and chemotherapy for locally recurrent stage III non-small cell lung cancer after concurrent chemoradiotherapy","volume":"15","author":"Yu","year":"2015","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.ctarc.2024.100844_bib0030","first-page":"84","article-title":"Combination treatment with iodine 125 seeds implant and systemic therapy vs. systemic therapy alone for non-small cell lung cancer: a systematic review and meta-analysis","volume":"33","author":"Li","year":"2023","journal-title":"J. Coll. Physicians Surg. Pak."},{"issue":"4","key":"10.1016\/j.ctarc.2024.100844_bib0031","first-page":"237","article-title":"The efficacy and safety of iodine-125 brachytherapy combined with chemotherapy in treatment of advanced lung cancer: a meta-analysis","volume":"27","author":"Qiu","year":"2017","journal-title":"J. Coll. Physicians Surg. Pak."},{"issue":"2","key":"10.1016\/j.ctarc.2024.100844_bib0032","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/crj.13283","article-title":"Radioactive seeds insertion with chemotherapy for advanced non-small-cell lung cancer: A meta-analysis","volume":"15","author":"Wu","year":"2021","journal-title":"Clin. Respir. J."},{"issue":"3","key":"10.1016\/j.ctarc.2024.100844_bib0033","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s11748-021-01710-5","article-title":"Impact of preoperative comorbidities on postoperative complication rate and outcome in surgically resected non-small cell lung cancer patients","volume":"70","author":"Benker","year":"2022","journal-title":"Gen. Thorac. Cardiovasc. Surg."},{"issue":"30","key":"10.1016\/j.ctarc.2024.100844_bib0034","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1200\/JCO.2006.07.5937","article-title":"Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer","volume":"24","author":"Timmerman","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ctarc.2024.100844_bib0035","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.radonc.2020.12.015","article-title":"Clinical and dosimetric predictors of radiation pneumonitis in early-stage lung cancer treated with Stereotactic Ablative radiotherapy (SABR)\u2013An analysis of UK's largest cohort of lung SABR patients","volume":"156","author":"Saha","year":"2021","journal-title":"Radiother. Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2024.100844_bib0036","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ijrobp.2019.03.045","article-title":"Local control after stereotactic body radiation therapy for stage I non-small cell lung cancer","volume":"110","author":"Lee","year":"2021","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.ctarc.2024.100844_bib0037","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s12032-014-0395-8","article-title":"Iodine-125 brachytherapy improved overall survival of patients with inoperable stage III\/IV non-small cell lung cancer versus the conventional radiotherapy","volume":"32","author":"Li","year":"2015","journal-title":"Med. Oncol."},{"issue":"2","key":"10.1016\/j.ctarc.2024.100844_bib0038","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.adro.2019.08.010","article-title":"Fatal radiation pneumonitis: literature review and case series","volume":"5","author":"Keffer","year":"2020","journal-title":"Adv. Radiat. Oncol."},{"key":"10.1016\/j.ctarc.2024.100844_bib0039","doi-asserted-by":"crossref","unstructured":"Y. Sun, Y.-L.Wu, C.-C. Zhou, L. Zhang, L. Zhang, X.-Y. Liu, S.-Y. Yu, G.-L. Jiang, K. Li, S.-K. Qin, S.-L. Ma, L. Han, M. Quinlivan, M. Orlando, X.-Q. Zhang, Second-line pemetrexed versus docetaxel in Chinese patients with locally advanced or metastatic non-small cell lung cancer: a randomized, open-label study. Lung Cancer. 79 (2) (2013) 143\u2013150, doi:10.1016\/j.lungcan.2012.10.015. Feb.","DOI":"10.1016\/j.lungcan.2012.10.015"},{"issue":"2","key":"10.1016\/j.ctarc.2024.100844_bib0040","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.radonc.2011.09.022","article-title":"Methods of verifying the output of the treatment planning system used for high dose rate (HDR) prostate brachytherapy","volume":"103","author":"Huckle","year":"2012","journal-title":"Radiother. Oncol."},{"issue":"3","key":"10.1016\/j.ctarc.2024.100844_bib0041","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4103\/jmp.JMP_22_17","article-title":"Magnitude, impact, and management of respiration-induced target motion in radiotherapy treatment: a comprehensive review","volume":"42","author":"Yoganathan","year":"2017","journal-title":"J. Med. Phys."},{"key":"10.1016\/j.ctarc.2024.100844_bib0042","doi-asserted-by":"crossref","first-page":"5457","DOI":"10.2147\/CMAR.S294313","article-title":"Efficacy and safety aiming at the combined-modality therapy of external beam radiotherapy (40Gy) and iodine-125 seed implantation for locally advanced NSCLC in the elderly","volume":"13","author":"Tian","year":"2021","journal-title":"Cancer Manag. Res."},{"issue":"1","key":"10.1016\/j.ctarc.2024.100844_bib0043","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s13014-016-0688-5","article-title":"Repeated iodine-125 seed implantations combined with external beam radiotherapy for the treatment of locally recurrent or metastatic stage III\/IV non-small cell lung cancer: a retrospective study","volume":"11","author":"Li","year":"2016","journal-title":"Radiat. Oncol."},{"issue":"3","key":"10.1016\/j.ctarc.2024.100844_bib0044","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.ijrobp.2022.12.049","article-title":"BRACHY: a randomized trial to evaluate symptom improvement in advanced non-small cell lung cancer treated with external beam radiation with or without high-dose-rate intraluminal brachytherapy","volume":"116","author":"Sur","year":"2023","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ctarc.2024.100844_bib0045","doi-asserted-by":"crossref","DOI":"10.1177\/17588359211018537","article-title":"Selection of optimal first-line immuno-related therapy based on specific pathological characteristics for patients with advanced driver-gene wild-type non-small cell lung cancer: a systematic review and network meta-analysis","volume":"13","author":"Sheng","year":"2021","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.ctarc.2024.100844_bib0046","doi-asserted-by":"crossref","unstructured":"S. Gettinger, L. Horn, D. Jackman, D. Spigel, S.Antonia, M.Hellmann, J. Powderly, R. Heist, L.V. Sequist, D.C. Smith, P. Leming, W.J. Geese, D. Yoon, A. Li, J. Brahmer, Five-year follow-up of nivolumab in previously treated advanced non-small-cell lung cancer: results from the CA209-003 study. J. Clin. Oncol. 36 (17) (2018) 1675\u20131684, doi:10.1200\/JCO.2017.77.0412. Jun 10.","DOI":"10.1200\/JCO.2017.77.0412"},{"issue":"28","key":"10.1016\/j.ctarc.2024.100844_bib0047","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1200\/JCO.19.00934","article-title":"Five-year overall survival for patients with advanced non\u2012small-cell lung cancer treated with pembrolizumab: results from the phase I KEYNOTE-001 study","volume":"37","author":"Garon","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.ctarc.2024.100844_bib0048","first-page":"4142","article-title":"Combination of pembrolizumab and 125I attenuates the aggressiveness of non-small cell lung cancer","volume":"19","author":"Wang","year":"2020","journal-title":"Oncol. Lett."},{"issue":"8","key":"10.1016\/j.ctarc.2024.100844_bib0049","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/j.clinthera.2020.05.018","article-title":"Clinical application of iodine-125 seed brachytherapy combined with anti-PD-1 antibodies in the treatment of lung cancer","volume":"42","author":"Sui","year":"2020","journal-title":"Clin. Ther."},{"issue":"20","key":"10.1016\/j.ctarc.2024.100844_bib0050","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1056\/NEJMoa1709937","article-title":"PACIFIC Investigators, Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer","volume":"377","author":"Antonia","year":"2017","journal-title":"New Engl. J. Med."},{"issue":"2","key":"10.1016\/j.ctarc.2024.100844_bib0051","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001001","article-title":"Pembrolizumab with or without radiation therapy for metastatic non-small cell lung cancer: a randomized phase I\/II trial","volume":"8","author":"Welsh","year":"2020","journal-title":"J. Immunother. Cancer."},{"issue":"12","key":"10.1016\/j.ctarc.2024.100844_bib0052","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1097\/JTO.0000000000000686","article-title":"Clinical trials integrating immunotherapy and radiation for non-small-cell lung cancer","volume":"10","author":"Daly","year":"2015","journal-title":"J. Thorac. Oncol."},{"issue":"7547","key":"10.1016\/j.ctarc.2024.100844_bib0053","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nature14292","article-title":"Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer","volume":"520","author":"Twyman-Saint Victor","year":"2015","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.ctarc.2024.100844_bib0054","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1001\/jamaoncol.2015.2756","article-title":"Role of local radiation therapy in cancer immunotherapy","volume":"1","author":"Demaria","year":"2015","journal-title":"JAMa Oncol."},{"issue":"3","key":"10.1016\/j.ctarc.2024.100844_bib0055","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1395996","article-title":"PD-1 blockade reverses adaptive immune resistance induced by high-dose hypofractionated but not low-dose daily fractionated radiation","volume":"7","author":"Morisada","year":"2017","journal-title":"Oncoimmunology"},{"issue":"5","key":"10.1016\/j.ctarc.2024.100844_bib0056","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ccr.2013.09.014","article-title":"Low-dose irradiation programs macrophage differentiation to an iNOS+\/M1 phenotype that orchestrates effective T cell immunotherapy","volume":"24","author":"Klug","year":"2013","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.ctarc.2024.100844_bib0057","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/carcin\/bgw007","article-title":"Low doses of gamma irradiation potentially modifies immunosuppressive tumor microenvironment by retuning tumor-associated macrophages: lesson from insulinoma","volume":"37","author":"Prakash","year":"2016","journal-title":"Carcinogenesis"},{"issue":"4","key":"10.1016\/j.ctarc.2024.100844_bib0058","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0039-6060(03)00327-1","article-title":"Comparison between sublobar resection and 125Iodine brachytherapy after sublobar resection in high-risk patients with Stage I non-small-cell lung cancer","volume":"134","author":"Santos","year":"2003","journal-title":"Surgery"},{"issue":"2","key":"10.1016\/j.ctarc.2024.100844_bib0059","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.athoracsur.2018.02.049","article-title":"Long-term results for clinical stage IA lung cancer: comparing lobectomy and sublobar resection","volume":"106","author":"Subramanian","year":"2018","journal-title":"Ann. Thorac. Surg."},{"issue":"3","key":"10.1016\/j.ctarc.2024.100844_bib0060","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/0003-4975(95)00537-U","article-title":"Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group","volume":"60","author":"Ginsberg","year":"1995","journal-title":"Ann. Thorac. Surg."},{"issue":"1","key":"10.1016\/j.ctarc.2024.100844_bib0061","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1053\/j.semtcvs.2010.04.003","article-title":"Sublobar resection with brachytherapy mesh for stage I non-small cell lung cancer","volume":"22","author":"Odell","year":"2010","journal-title":"Semin. Thorac. Cardiovasc. Surg."},{"issue":"1","key":"10.1016\/j.ctarc.2024.100844_bib0062","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3857\/roj.2016.01928","article-title":"Long-term outcomes after salvage radiotherapy for postoperative locoregionally recurrent non-small-cell lung cancer","volume":"35","author":"Kim","year":"2017","journal-title":"Radiat. Oncol. J."},{"issue":"2","key":"10.1016\/j.ctarc.2024.100844_bib0063","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.athoracsur.2005.08.052","article-title":"Sublobar resection with brachytherapy versus lobectomy for stage Ib nonsmall cell lung cancer","volume":"81","author":"Birdas","year":"2006","journal-title":"Ann. Thorac. Surg."},{"issue":"23","key":"10.1016\/j.ctarc.2024.100844_bib0064","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1200\/JCO.2013.53.4115","article-title":"Impact of brachytherapy on local recurrence rates after sublobar resection: results from ACOSOG Z4032 (Alliance), a phase III randomized trial for high-risk operable non-small-cell lung cancer","volume":"32","author":"Fernando","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ctarc.2024.100844_bib0065","doi-asserted-by":"crossref","first-page":"10581","DOI":"10.2147\/OTT.S272898","article-title":"125I Seed brachytherapy combined with single-agent chemotherapy in the treatment of non-small-cell lung cancer in the elderly: A valuable solution","volume":"13","author":"Yue","year":"2020","journal-title":"OncoTargets Ther"},{"key":"10.1016\/j.ctarc.2024.100844_bib0066","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1176083","article-title":"I-125 seeds brachytherapy combined with immunotherapy for MET amplification in non-small cell lung cancer from clinical application to related lncRNA mechanism explore: a case report","volume":"11","author":"Yang","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"issue":"2","key":"10.1016\/j.ctarc.2024.100844_bib0067","doi-asserted-by":"crossref","first-page":"223","DOI":"10.11152\/mu-4406","article-title":"Lung ultrasound manifestations of right lung squamous cell carcinoma with iodine-125 seeds implantation","volume":"26","author":"Zhao","year":"2024","journal-title":"Med. Ultrason."},{"issue":"1","key":"10.1016\/j.ctarc.2024.100844_bib0068","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s11701-024-01957-z","article-title":"Experimental validation of the accuracy of robotic-assisted radioactive seed implantation for tumor treatment","volume":"18","author":"Ji","year":"2024","journal-title":"J. Robot. Surg."}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246829422400056X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246829422400056X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T13:14:04Z","timestamp":1733058844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S246829422400056X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":68,"alternative-id":["S246829422400056X"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2024.100844","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A review of the efficacy and safety of iodine-125 seed implantation for lung cancer treatment","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2024.100844","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100844"}}